Table 3.

Efficacy data summary

Efficacy endpointPatients (N = 39)
Median PFS, mo (95% CI)1.5 (1.4–1.7)
Median OS, mo (95% CI)3.2 (2.3–8.1)
ORR, % (95% CI)2.6 (0.1–13.5)
Best response, n (%)
 PR1 (2.6)
 SD9 (23.1)
 PD16 (41.0)
 Inevaluablea13 (33.3)

Abbreviation: ORR, overall response rate.

  • aBaseline tumor data only.